Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary pleuropulmonary sarcoma: a rare disease entity.
Giaj Levra M, Novello S, Scagliotti GV, Papotti M, Le Cesne A. Giaj Levra M, et al. Clin Lung Cancer. 2012 Nov;13(6):399-407. doi: 10.1016/j.cllc.2012.05.003. Epub 2012 Jun 5. Clin Lung Cancer. 2012. PMID: 22673623 No abstract available.
MET inhibition in lung cancer.
Menis J, Giaj Levra M, Novello S. Menis J, et al. Transl Lung Cancer Res. 2013 Feb;2(1):23-39. doi: 10.3978/j.issn.2218-6751.2012.12.04. Transl Lung Cancer Res. 2013. PMID: 25806202 Free PMC article. Review.
Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.
Giaj-Levra N, Giaj-Levra M, Durieux V, Novello S, Besse B, Hasan B, Hendriks LE, Levy A, Dingemans AC, Berghmans T; European Organization for Research and Treatment of Cancer-Lung Cancer Group. Giaj-Levra N, et al. J Thorac Oncol. 2019 Dec;14(12):2053-2061. doi: 10.1016/j.jtho.2019.05.037. Epub 2019 Jun 11. J Thorac Oncol. 2019. PMID: 31195177 Free article.
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
Dingemans AC, Hendriks LEL, Berghmans T, Levy A, Hasan B, Faivre-Finn C, Giaj-Levra M, Giaj-Levra N, Girard N, Greillier L, Lantuéjoul S, Edwards J, O'Brien M, Reck M, Smit EF, Van Schil P, Postmus PE, Ramella S, Lievens Y, Gaga M, Peled N, Scagliotti GV, Senan S, Paz-Ares L, Guckenberger M, McDonald F, Ekman S, Cufer T, Gietema H, Infante M, Dziadziuszko R, Peters S, Porta RR, Vansteenkiste J, Dooms C, de Ruysscher D, Besse B, Novello S. Dingemans AC, et al. J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6. J Thorac Oncol. 2019. PMID: 31398540 Free article.
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
Hendriks LEL, Dooms C, Berghmans T, Novello S, Levy A, De Ruysscher D, Hasan B, Giaj Levra M, Giaj Levra N, Besse B, Vansteenkiste J, Dingemans AC; European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group. Hendriks LEL, et al. Eur J Cancer. 2019 Dec;123:28-35. doi: 10.1016/j.ejca.2019.09.013. Epub 2019 Oct 23. Eur J Cancer. 2019. PMID: 31655358 Free article.
Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.
Landi L, Tiseo M, Chiari R, Ricciardi S, Rossi E, Galetta D, Novello S, Milella M, D'Incecco A, Minuti G, Tibaldi C, Salvini J, Facchinetti F, Haspinger ER, Cortinovis D, Santo A, Banna G, Catino A, GiajLevra M, Crinò L, de Marinis F, Cappuzzo F. Landi L, et al. Clin Lung Cancer. 2014 Nov;15(6):411-417.e4. doi: 10.1016/j.cllc.2014.07.002. Epub 2014 Aug 16. Clin Lung Cancer. 2014. PMID: 25242668 Free article.
35 results